• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺癌合并上腔静脉切除术:上腔静脉侵犯模式的预后意义

Combined resection of superior vena cava for lung carcinoma: prognostic significance of patterns of superior vena cava invasion.

作者信息

Suzuki Kenji, Asamura Hisao, Watanabe Shun-ichi, Tsuchiya Ryosuke

机构信息

Thoracic Surgery Division, National Cancer Center Hospital, Tokyo, Japan.

出版信息

Ann Thorac Surg. 2004 Oct;78(4):1184-9; discussion 1184-9. doi: 10.1016/j.athoracsur.2004.04.066.

DOI:10.1016/j.athoracsur.2004.04.066
PMID:15464467
Abstract

BACKGROUND

Combined resection of the superior vena cava (SVC) for lung carcinoma remains challenging in terms of technical aspect and prognosis. We attempted to clarify the surgical outcome of combined resection and reconstruction of the SVC for lung carcinoma.

METHODS

Between March 1980 and May 2001, among 3,499 lung resections, 40 (1.1%) patients underwent combined resection of the SVC. Thirty-four were men and 6 were women. Ages ranged from 37 to 77 years, with median of 64 years. Lobectomy and pneumonectomy was performed in 19 and 21 patients, respectively. The SVC system was totally resected and reconstructed with grafts in 11 patients, and partially resected in 29 patients. For the latter patients, autologous pericardial patches were used in 8 patients, and a running direct suture was performed in 21 patients. The survival curves were constructed by the method of Kaplan-Meier, and the curves were compared using the log-rank test.

RESULTS

Thirty-day mortality was 10%. The 5-year survival rate was 24%, with the median follow-up period for living patients 67 months (actual 5-year survivors were 7). The prognoses were compared between patients with SVC invasion by metastatic nodes (n = 15) and those with SVC invasion by a direct tumor extension (n = 25), and the survival difference was statistically significant (5-year survival rate, 6.6% versus 36%; p = 0.05).

CONCLUSIONS

The pattern of SVC invasion was considered to be a significant prognostic factor, and this factor should be taken into consideration for evaluating the outcome of clinical trials for T4 lung cancer.

摘要

背景

肺癌合并上腔静脉(SVC)切除在技术层面和预后方面仍然具有挑战性。我们试图阐明肺癌合并SVC切除及重建的手术结果。

方法

在1980年3月至2001年5月期间,在3499例肺切除病例中,40例(1.1%)患者接受了SVC联合切除。男性34例,女性6例。年龄范围为37至77岁,中位年龄为64岁。19例和21例患者分别进行了肺叶切除和全肺切除。11例患者的SVC系统被完全切除并用移植物重建,29例患者的SVC系统被部分切除。对于后一组患者,8例使用了自体心包补片,21例进行了连续直接缝合。采用Kaplan-Meier方法构建生存曲线,并使用对数秩检验比较曲线。

结果

30天死亡率为10%。5年生存率为24%,存活患者的中位随访期为67个月(实际5年幸存者为7例)。比较了转移性淋巴结侵犯SVC的患者(n = 15)和肿瘤直接侵犯SVC的患者(n = 25)的预后,生存差异具有统计学意义(5年生存率,6.6%对36%;p = 0.05)。

结论

SVC侵犯模式被认为是一个重要的预后因素,在评估T4期肺癌的临床试验结果时应考虑这一因素。

相似文献

1
Combined resection of superior vena cava for lung carcinoma: prognostic significance of patterns of superior vena cava invasion.肺癌合并上腔静脉切除术:上腔静脉侵犯模式的预后意义
Ann Thorac Surg. 2004 Oct;78(4):1184-9; discussion 1184-9. doi: 10.1016/j.athoracsur.2004.04.066.
2
Results of superior vena cava resection for lung cancer. Analysis of prognostic factors.肺癌上腔静脉切除的结果。预后因素分析。
Lung Cancer. 2004 Jun;44(3):339-46. doi: 10.1016/j.lungcan.2003.11.010.
3
[Resection for lung cancer invading the superior vena cava].[侵犯上腔静脉的肺癌切除术]
Zhonghua Wai Ke Za Zhi. 2006 Mar 15;44(6):402-4.
4
15 years single center experience with surgical resection of the superior vena cava for non-small cell lung cancer.15年单中心非小细胞肺癌上腔静脉手术切除经验。
Lung Cancer. 2004 Sep;45(3):357-63. doi: 10.1016/j.lungcan.2004.02.009.
5
[Surgical results of T4 lung cancer invading left atrium and great vessels].[侵犯左心房及大血管的T4期肺癌的手术结果]
Zhonghua Yi Xue Za Zhi. 2008 Feb 5;88(6):383-6.
6
Long-term follow-up after prosthetic replacement of the superior vena cava combined with resection of mediastinal-pulmonary malignant tumors.上腔静脉人工血管置换联合纵隔-肺恶性肿瘤切除术后的长期随访
J Thorac Cardiovasc Surg. 1991 Aug;102(2):259-65.
7
Review of superior vena cava resection in the management of benign disease and pulmonary or mediastinal malignancies.上腔静脉切除术在良性疾病以及肺部或纵隔恶性肿瘤治疗中的应用综述
Ann Thorac Surg. 2009 Aug;88(2):392-7. doi: 10.1016/j.athoracsur.2009.04.068.
8
Surgical management of lung cancer invading the aorta or the superior vena cava.侵犯主动脉或上腔静脉的肺癌的外科治疗
Lung Cancer. 2007 May;56(2):223-7. doi: 10.1016/j.lungcan.2006.12.008. Epub 2007 Jan 16.
9
Results of primary surgery with T4 non-small cell lung cancer during a 25-year period in a single center: the benefit is worth the risk.单中心25年间T4期非小细胞肺癌的初次手术结果:获益值得冒险。
Ann Thorac Surg. 2008 Oct;86(4):1065-75; discussion 1074-5. doi: 10.1016/j.athoracsur.2008.07.004.
10
Superior vena cava resection for lung and mediastinal malignancies: a single-center experience with 70 cases.上腔静脉切除术治疗肺和纵隔恶性肿瘤:单中心70例经验
Ann Thorac Surg. 2007 Jan;83(1):223-9; discussion 229-30. doi: 10.1016/j.athoracsur.2006.07.075.

引用本文的文献

1
A Systematic Review of Surgical Strategies for Managing Major Thoracic Vessels in Thoracic Oncology.胸科肿瘤学中处理主要胸段血管的手术策略的系统评价
Ann Surg Oncol. 2025 Mar 17. doi: 10.1245/s10434-025-17159-2.
2
Internal jugular vein pressure monitoring guided venous reconstruction could improve perioperative safety after superior vena cava resection for mediastinal tumors: a cohort study.颈内静脉压监测指导下的静脉重建可提高纵隔肿瘤上腔静脉切除术后围手术期安全性:一项队列研究。
Int J Surg. 2024 May 1;110(5):2730-2737. doi: 10.1097/JS9.0000000000001150.
3
Lung cancer invading the superior vena cava - surgical treatment. A short and up-to-date review.
肺癌侵犯上腔静脉——外科治疗。简短的最新综述。
Kardiochir Torakochirurgia Pol. 2023 Jun;20(2):105-110. doi: 10.5114/kitp.2023.129546. Epub 2023 Jul 26.
4
Superior Vena Cava Resection in Locally Advanced Thymoma-Surgical and Survival Outcomes.局部晚期胸腺瘤的上腔静脉切除术——手术及生存结果
Indian J Surg Oncol. 2020 Dec;11(4):711-719. doi: 10.1007/s13193-020-01204-5. Epub 2020 Sep 4.
5
Superior vena cava resection and reconstruction in mediastinal tumors and benign diseases.纵隔肿瘤及良性疾病中的上腔静脉切除与重建
Turk Gogus Kalp Damar Cerrahisi Derg. 2018 Jan 9;26(1):99-107. doi: 10.5606/tgkdc.dergisi.2018.14292. eCollection 2018 Jan.
6
Initial extended resection or neoadjuvant therapy for T4 non-small cell lung cancer-What is the evidence?T4期非小细胞肺癌的初始扩大切除术或新辅助治疗——证据是什么?
Shanghai Chest. 2018 Oct;2. doi: 10.21037/shc.2018.09.08. Epub 2018 Oct 11.
7
Is postoperative anticoagulation necessary after left innominate vein division in general thoracic surgery?普通胸外科手术中左无名静脉离断术后是否需要进行抗凝治疗?
Gen Thorac Cardiovasc Surg. 2019 Feb;67(2):254-258. doi: 10.1007/s11748-018-1019-6. Epub 2018 Oct 29.
8
A two-step surgical approach combining sternotomy and subsequent thoracotomy for locally advanced lung cancers requiring both right upper lung resection and superior vena cava reconstruction.一种两步手术方法,结合胸骨切开术及后续开胸术,用于需要同时进行右上肺切除和上腔静脉重建的局部晚期肺癌。
J Thorac Dis. 2018 Aug;10(8):4831-4837. doi: 10.21037/jtd.2018.07.77.
9
Is Surgery after Chemoradiotherapy Feasible in Lung Cancer Patients with Superior Vena Cava Invasion?放化疗后手术对伴有上腔静脉侵犯的肺癌患者是否可行?
Ann Thorac Cardiovasc Surg. 2018 Jun 20;24(3):131-138. doi: 10.5761/atcs.oa.18-00027. Epub 2018 Apr 20.
10
Long-term survival in locally advanced non-small cell lung cancer invading the great vessels and heart.局部晚期侵犯大血管和心脏的非小细胞肺癌的长期生存。
Thorac Cancer. 2018 May;9(5):598-605. doi: 10.1111/1759-7714.12625. Epub 2018 Mar 30.